Pharma Mar | PHM - Stock

Aktienkurs
97.15
Täglich Wechseln
0.30 0.31%
Monatlich
12.38%
Jährlich
34.74%
Q2 Prognose
92.25




Stock Veränderung Datum
Akebia Therapeutics USD 15.61M 3.03M 2025-12
Almirall EUR 178.13M 1.54M 2025-12
Avita Medical AUD 6.93M 614K 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Laboratorios Farma EUR 327.67M 2.28M 2025-06
Moderna USD 332M 92M 2025-09
Organon & Co USD 1.49B 34M 2025-09
Pharma Mar EUR 50.64M 1.13M 2025-12
Revvity USD 379.5M 420K 2025-12
Viatris USD 4B 112.2M 2025-12
Xeris Pharmaceuticals USD 68.67M 1.21M 2025-12